Summary

AtriCure, Inc. is a leading medical device company specializing in innovative technologies for the treatment of atrial fibrillation (Afib) and related cardiac conditions. Founded in 2000 and headquartered near Cincinnati, Ohio, the company develops and manufactures advanced surgical ablation systems and left atrial appendage management devices. AtriCure's flagship product, the Isolator® Synergy™ Ablation System, holds the distinction of being the first medical device to receive FDA approval for the treatment of persistent Afib. The company's AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with over 700,000 devices sold globally. AtriCure also offers Hybrid AF™ Therapy, a minimally invasive procedure for long-standing persistent Afib patients, and cryoICE cryoSPHERE® probes for temporary ablation of peripheral nerves to manage post-operative pain. With products sold in approximately 50 countries, over 1,300 employees worldwide, and more than 450 scientists and engineers, AtriCure serves over 650,000 patients with ablation worldwide and has trained more than 4,600 healthcare professionals. The company maintains a strong focus on clinical science, education, and innovation to improve patient outcomes in cardiac care.

Job description

What Impact You Can Make as a Cryo Nerve Block Territory Manager

Drive institutional therapy adoption of AtriCure's Cryo Nerve Block Therapy for acute post-operative pain relief in cardiothoracic and other procedures involving the chest wall.
Develop, implement and execute a strategic business plan for a designated territory to achieve assigned objectives
Continually identify new customers, contacts and opportunities
Increase penetration and adoption within existing accounts to build upon and grow the base business
Identify and educate key health care professionals that manage post-operative pain in the hospital setting
Manage and coordinate customer visits, educational programs, procedural observations, proctoring, and relevant tradeshow participation
Form relationships with hospital administration to understand hospital dynamics; develop and present the value proposition of the therapy for administrative buy-in
Work closely with the Director of Sales to implement and execute strategies to achieve corporate objectives
Responsible for understanding and satisfying the requirements for obtaining access to a hospital, healthcare system, or other client site

What You Bring

Bachelor's degree or demonstrated equivalent combination of education, training and experience
Specific knowledge and selling or support experience related to post-operative pain management is an asset
A documented track record of successful sales quota achievement in the medical device industry
Strong clinical and technical aptitude
Ability to travel up to 40-60% depending on territory
Ability to pass account and hospital credentialing

Requirements

Bachelor's degree or demonstrated equivalent combination of education, training and experience
Specific knowledge and selling or support experience related to post-operative pain management is an asset
A documented track record of successful sales quota achievement in the medical device industry
Strong clinical and technical aptitude
Ability to travel up to 40-60% depending on territory
Ability to pass account and hospital credentialing

Benefits

Medical, Dental & Vision
Health Savings Account
401(k) Matching
Volunteer Time Off
Extended Parental Leave
Employee Stock Purchase Program
Tuition Reimbursement
Car Allowance
Gas Reimbursement
Cell Phone Reimbursement
Wellness Programs
Pet Insurance

Company overview

AtriCure, Inc. is a leading medical device company specializing in innovative technologies for the treatment of atrial fibrillation (Afib) and related cardiac conditions. Founded in 2000 and headquartered near Cincinnati, Ohio, the company develops and manufactures advanced surgical ablation systems and left atrial appendage management devices. AtriCure's flagship product, the Isolator® Synergy™ Ablation System, holds the distinction of being the first medical device to receive FDA approval for the treatment of persistent Afib. The company's AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with over 700,000 devices sold globally. AtriCure also offers Hybrid AF™ Therapy, a minimally invasive procedure for long-standing persistent Afib patients, and cryoICE cryoSPHERE® probes for temporary ablation of peripheral nerves to manage post-operative pain. With products sold in approximately 50 countries, over 1,300 employees worldwide, and more than 450 scientists and engineers, AtriCure serves over 650,000 patients with ablation worldwide and has trained more than 4,600 healthcare professionals. The company maintains a strong focus on clinical science, education, and innovation to improve patient outcomes in cardiac care.